SecBot SecBot
144 ·Filed Oct 1, 2026

XFOR

X4 Pharmaceuticals, Inc
NEUTRAL
Impact 2/10
Horizonimmediate Processed25d 7h ago SEC0001276750-26-000008
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine tax-withholding sale with no discretionary signal. Monitor for any subsequent discretionary Form 4 filings by officers, which would carry more weight.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
XFOR ▲ +2.83% at T+5d
NEUTRAL call +2.83% · α vs SPY +1.67% · entry $2.83 → $2.91
Next anchor: T+20d in 2d
Latest observation: T+15 +25.06% FF3 residual α
Entry = T+0 close
Oct 1, 2026
via day close
T+1d
+2.47%
call +2.47% · α +1.80%
$2.90
settled 25d ago
T+5d
+2.83%
call +2.83% · α +1.67%
$2.91
settled 19d ago
T+20d
Pending
in 2d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

David Kirske, an officer of X4 Pharmaceuticals, filed a Form 144 notice of intent to sell 11,767 common shares (approx. $33,658) to cover tax withholding obligations from vesting restricted stock units. The sale is mandatory under the company's equity incentive plans and is not a discretionary trade by the insider.

Key Facts

  • Insider David Kirske (Officer) filed Form 144 to sell 11,767 shares of X4 Pharmaceuticals common stock.
  • Estimated aggregate sale value is approximately $33,658.47 based on filing date price.
  • Sale is mandated by the issuer's equity incentive plan to cover tax withholding on vested restricted stock units.
  • Transaction is a 'sell to cover' — not a discretionary trade by the insider.
  • Filing date: October 1, 2026.

Financial Impact

Approximately $33,658 in planned sale, representing a small fraction of the company's market cap.

dilution

Risk Factors

  • No material risk identified from this filing alone.

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001276750-26-000008
Document: 0001276750-26-000008-index.html0001276750-26-000008
Document: 0001276750-26-000008.txt0001276750-26-000008
15 reports for XFOR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for XFOR — sortable, filterable
TypeNow
Oct 8, 2026
18d ago
8-K
MIXED ★ 6/10
$2.91awaiting T+20—$3.25 (+11.68%)
Oct 7, 2026
19d ago
SC 13G/A
NEUTRAL ★ 3/10
$2.81awaiting T+20—$3.25 (+15.66%)
Oct 1, 2026
25d ago
144
NEUTRAL ★ 2/10
$2.83awaiting T+20—$3.25 (+14.84%)
Sep 21, 2026
5w ago
SC 13G
NEUTRAL ★ 4/10
$3.43 $3.02▼ −11.95%▼ −11.39%$3.25 (−5.25%)
Sep 8, 2026
6w ago
8-K
BULLISH ★ 6/10
$3.51 $2.77▼ −20.97%▼ −22.68%$3.25 (−7.28%)
Aug 13, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$4.22 $3.62▼ −14.22%▼ −12.23%$3.25 (−22.99%)
Aug 13, 2026
10w ago
144
NEUTRAL ★ 2/10
$4.29 $3.50▼ −18.41%▼ −16.67%$3.25 (−24.24%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 2/10
$3.88 $3.96▲ +2.06%▲ +0.17%$3.25 (−16.24%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$3.88 $3.96▲ +2.06%▲ +0.17%$3.25 (−16.24%)
May 18, 2026
23w ago
EFFECT
NEUTRAL ★ 4/10
$3.68 $4.04▲ +9.78%▲ +8.20%$3.25 (−11.68%)
Showing 10 of 15

US Market Status

Market Closed — Opens in 5h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 1, 2026